Navigation Links
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Date:4/29/2008

rently require from Insmed," noted Dr. Geoffrey Allan, CEO of Insmed. "The market potential for MMD alone is estimated in excess of $800 million. Thus, we consider our current program for IPLEX(TM) one of minimal risk and high potential reward. Also, our substantial capabilities in the evolving, potential multi-billion dollar, follow-on biologics industry provide us with a unique growth driver not available to the vast majority of biotechnology companies our size. As evidenced by the initiation of the INS-19 clinical trial in the UK, we are committed to being at the forefront of the follow-on-biologics market. We remain confident that our company will be one of the few initial U.S. follow-on-biologics market entrants upon the establishment of a regulatory pathway, and look forward to providing patients with cost-effective access to important biotechnology medications when the innovator products come off patent."

About INS-19

Recombinant human G-CSF is a protein that is produced in bacterial cells and is used to treat certain medical conditions where a person's neutrophils are too low (neutropenia), such as in cancer patients who are receiving certain chemotherapeutic regimens, patients receiving bone marrow transplants, or in patients who have chronically low neutrophils for other reasons. The FDA approved version of this drug is Neupogen(R). INS-19 is Insmed's follow-on biologic version of Neupogen(R).

About INS-20

Pegylated recombinant human G-CSF is a chemically modified version of G-CSF in which a water soluble polymer called polyethylene glycol is attached to the protein. The pegylated protein has a prolonged biological activity after it is injected into the patient. This allows less frequent dosing for the patient compared to recombinant human G-CSF. The FDA approved version of this drug is Neulasta(R). INS-20 is Insmed's follow-on biologic version of Neulasta(R).

About IPLEX(TM)

IPLEX(TM) was approved in the United St
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
6. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
10. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced ... UK - November 19-20, 2015)" conference to their ... cover industry case studies, regulatory updates, latest therapies and ... Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar Pharma ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Drug Delivery in ... Companies" to their offering. ... the BBB have opened new avenues and possibilities ... carrier or transport systems, enzymes, and receptors that ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on ... expansion of its U.S. commercial operations team to include a ... of Commercial Operations. , Timothy Arendt has ... the U.S. specialty sales force for Qutenza(TM). , ...
... A drug already approved for the treatment of lymphoma may ... in children and teens, according to an early-stage study published ... The study drug, Bortezomib, was found to be effective against ... While key experiments were in animals, the cancer studied closely ...
Cached Medicine Technology:NeurogesX Expands Commercial Operations Leadership Team 2NeurogesX Expands Commercial Operations Leadership Team 3NeurogesX Expands Commercial Operations Leadership Team 4NeurogesX Expands Commercial Operations Leadership Team 5NeurogesX Expands Commercial Operations Leadership Team 6Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 2Approved Lymphoma Drug Shows Promise in Early Tests Against Bone Cancer 3
(Date:9/3/2015)... , ... September 03, 2015 , ... At Renew Man™, ... dissatisfied with the traditional health care model, where the primary care physician dictates and ... who want to become educated about their health issues and empowered to choose their ...
(Date:9/3/2015)... , ... September 03, 2015 , ... Local filmmakers and ... Hannah & Michael Habernig from Path 11 Productions have had great success in launching ... podcast has featured Hay House authors, Teal Swan who is the well known Spiritual ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa ... health professionals out there. His perspective on internal medicine keeps patients happy and healthy, ... healthy is important regardless of the season, but even more so in the fall, ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic (TAC), ... retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. ... developing a whole mind-body approach to fitness - we are much more than a ...
(Date:9/2/2015)... , ... September 03, 2015 , ... ... Johns Hopkins University Bloomberg School of Public Health and an internationally recognized scholar ... Fellows program for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate of ...
Breaking Medicine News(10 mins):Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... that the people of India constitute more than ... been underrepresented in studies related //to genetic diseases. ... diseases associated with urban and western lifestyles have ... association studies of particular importance. ,In ...
... comparing the safety, effectiveness and reliability of LASIK and LASEK ... of laser eye// surgery. ,The study, led by ... the December 2006 issue of the American Journal of Ophthalmology. ... safety and efficacy of both types of laser surgery, there ...
... Biology, members of Dr. John Herr’s laboratory at the ... a new protein within a sperm’s tail that could ... ,“There’s considerable interest in developing new male contraceptives,” ... Contraceptive and Reproductive Health. “To support this effort, our ...
... somehow delay the greying process continues with gusto into the ... Youthfulness always pouts with tantalising// appeal. The latest from scientists ... If the DNA within a living cell gets damaged, it ... especially true if the cell is too weak to help ...
... the repercussions of a potential flu pandemic showed that nearly ... nations, could pay// with their life. , ,The ... Spanish flu, which wiped out nearly 20 million people in ... Health and the University of Queensland studied the data gathered ...
... Researcher predict that in the years ahead, medical science ... transform medicine for various treatments will stand to// reshape ... dean of the health-planning department at Eastern Virginia Medical ... based on these technologies. ,'Fat Fryer' Device ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Study Compares LASIK and LASEK Eye Surgery 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2Health News:Clues to Allay Aging 2Health News:Medical Science Miracles – Coming Your Wa 2